ValiRx plc (GB:VAL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ValiRx plc, a life science company specializing in early-stage cancer therapeutics and women’s health, invites shareholders to an interactive webinar with CEO Dr. Mark Eccleston on 21st October 2024. The presentation will discuss the company’s vision and future direction, with on-demand access post-event on their website. ValiRx is known for its approach to accelerating the development of innovative medicines, with lead candidates being outlicensed for further development and commercialization.
For further insights into GB:VAL stock, check out TipRanks’ Stock Analysis page.